Sanofi has entered into a licensing agreement with Adel, a clinical-stage biotech based in Seoul, South Korea, for the development... Read more
Category: Uncategorized
Alphyn Biologics Secures $25 Million in Series B Funding
Alphyn Biologics, a US-based biotechnology company, has successfully completed a Series B funding round, raising $25 million. The round was... Read more
SOBI Agrees to Acquire Arthrosi Therapeutics
Swedish Orphan Biovitrum (SOBI) has reached an agreement to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly... Read more
Pharmaceutical Manufacturer Gaelic Labs Acquires Athlone Laboratories
Gaelic Laboratories, a pharmaceutical manufacturer specializing in Beta-Lactam (penicillin) products, has acquired Athlone Laboratories, a developer and manufacturer of oral... Read more
Strategic Partnership Expanded Between Dren Bio and Sanofi for Next-Generation B-Cell Therapy
Dren Bio, a privately held, clinical-stage biotechnology company, announced an expanded strategic collaboration with Sanofi for the discovery and development... Read more
PARP Combination Therapy Expands Treatment Indication in Prostate Cancer
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for a targeted combination therapy for patients with... Read more
J&J Multiple Myeloma Drug Regimen Receives Proactive National Priority Review Voucher from the FDA
The U.S. Food and Drug Administration (FDA) has "proactively" awarded Johnson & Johnson (J&J) a Commissioner’s National Priority Voucher (CNPV)... Read more
Novel Combination Therapy Gains Initial Approval for Metastatic Breast Cancer Treatment
The U.S. Food and Drug Administration (FDA) recently granted approval for a new combination regimen for patients with unresectable or... Read more
National Occupational Health Provider Extends Reach in Florida
Occupational health specialist Concentra (NYSE:CON), a publicly traded company, has expanded its national footprint by establishing a new medical center... Read more








